The 12 closest competitors and alternatives to For The Biome, LLC among biotechnology companies — ranked by similarity to what For The Biome, LLC actually does, not by market-cap band.
Subscribe to see For The Biome, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
The OpenBiome Foundation expands patient access to microbiome therapies and drives scientific discovery to advance human health. The organization provides resources, strategic collaborations, and investments to equip clinicians, researchers, and healthcare systems with tools for microbiome-directed treatments.
For The Biome, LLC is a biotechnology company headquartered in United States. Its most recent funding round raised $2.9M in April 2022. Xcout tracks 9 named people at For The Biome, LLC, including Julie Barrett O’Brien (Foundation CEO).
3 more named people on record for For The Biome, LLC, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $2.9M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to For The Biome, LLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Anto Biosciences is a frontier biology AI lab founded in 2025, focusing on developing a foundation model for microbial communities.
Similar biotechnology company
Exa Biosciences builds infrastructure solutions designed to power the development of next-generation therapeutic biologics. The company provides foundational support and technologies tailored for organizations and researchers working in the biotherapeutic sector.
Similar biotechnology company
Biora Therapeutics is a U.S. biotechnology company developing ingestible, device-based platforms for delivering biologic medicines to targeted areas of the gastrointestinal tract and into systemic circulation. Its technologies are intended for use by pharmaceutical and biotechnology companies developing oral or targeted biologic therapies.
Similar biotechnology company
Opal Biosciences (operating as Opal Therapeutics) is a biotechnology company that develops patient-derived uterine organoids to model human reproductive biology. The company provides research and drug discovery platforms to help researchers study conditions like endometriosis and uterine fibroids, serving the biotechnology and pharmaceutical research sectors.
Similar biotechnology company
Codebreaker Bioscience is a privately held bioscience platform startup founded in 2023 that develops microbiome-related solutions and is based in Chile.
Biotech
Variant Bio, Inc. is a biotechnology company that uses human genomic diversity and population genetics to discover therapeutic targets and develop medicines. It works with researchers, healthcare and biotechnology partners, and genetically diverse communities to study traits associated with health and disease.
Biotech
General Biotechnologies develops programmable synthetic biology platforms that use edible microbes to manufacture and deliver peptide therapeutics. The company primarily serves the pharmaceutical industry by reformulating discontinued peptide drugs into low-cost, needle-free oral medications and providing field-deployable biomanufacturing kits.
Similar biotechnology company
BiomeBank develops and commercializes microbiome therapeutics designed to restore gut ecological complexity and treat human diseases. The company offers regulated donor-derived therapies, such as BIOMICTRA for recurrent Clostridioides difficile infections, and is advancing a pipeline of next-generation co-cultured microbial products for conditions spanning immunology, metabolism, and oncology. It serves medical practitioners and patients by providing clinically informed gut health treatments.
Similar biotechnology company
BioCollective, LLC provides products and services for microbiome research, serving researchers, academic institutions, and biotechnology companies. The company offers patented fecal collection kits, standardized reference samples, a fecal sample bank with diverse population data, and computational metabolic modeling services to support multi-omic analysis and product development.
Biotech
ClostraBio, Inc. is a Chicago-based biotechnology research company pioneering microbiome-based solutions, next-generation probiotics for gut health, and advanced metabolite delivery solutions for inflammatory bowel disease.
Similar biotechnology company
Federation Bio is a U.S. biotechnology company developing live biotherapeutic products based on defined microbial communities to treat diseases. Its work has focused on microbiome-based therapies for metabolic and other serious disorders, serving patients with conditions that may benefit from engineered microbial consortia.
Similar biotechnology company
Exeliom Biosciences is a clinical-stage biopharmaceutical company headquartered in France that develops novel therapeutic approaches harnessing microbiome-host interactions.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for For The Biome, LLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →